Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rabies virus | 2 | 2017 | 92 | 0.84 | Why? |
| Rabies | 2 | 2017 | 113 | 0.78 | Why? |
| Post-Exposure Prophylaxis | 1 | 2017 | 472 | 0.50 | Why? |
| Antiviral Agents | 16 | 2021 | 41703 | 0.46 | Why? |
| Virus Replication | 12 | 2021 | 14331 | 0.42 | Why? |
| Itraconazole | 2 | 2021 | 135 | 0.40 | Why? |
| Chikungunya virus | 3 | 2018 | 339 | 0.40 | Why? |
| STAT2 Transcription Factor | 2 | 2020 | 141 | 0.36 | Why? |
| Coronavirus NL63, Human | 2 | 2015 | 669 | 0.33 | Why? |
| High-Throughput Screening Assays | 3 | 2021 | 1783 | 0.29 | Why? |
| Cysteine Proteinase Inhibitors | 2 | 2021 | 675 | 0.26 | Why? |
| Coronavirus 229E, Human | 4 | 2021 | 1241 | 0.25 | Why? |
| Vero Cells | 10 | 2021 | 14117 | 0.22 | Why? |
| Nucleotidyltransferases | 1 | 2021 | 77 | 0.22 | Why? |
| Oleanolic Acid | 1 | 2021 | 82 | 0.21 | Why? |
| Furans | 1 | 2021 | 156 | 0.21 | Why? |
| Epithelial Cells | 3 | 2021 | 3508 | 0.20 | Why? |
| Stilbenes | 1 | 2021 | 113 | 0.20 | Why? |
| Triazines | 1 | 2021 | 246 | 0.19 | Why? |
| Viral Nonstructural Proteins | 4 | 2021 | 4810 | 0.19 | Why? |
| Mannitol | 1 | 2017 | 34 | 0.18 | Why? |
| Nerve Tissue Proteins | 1 | 2021 | 319 | 0.18 | Why? |
| Enzyme Inhibitors | 2 | 2021 | 1881 | 0.18 | Why? |
| Pyrroles | 1 | 2021 | 292 | 0.18 | Why? |
| Amides | 2 | 2021 | 1864 | 0.18 | Why? |
| Adenosine | 2 | 2021 | 509 | 0.17 | Why? |
| Genome, Human | 1 | 2021 | 400 | 0.17 | Why? |
| Quinolines | 1 | 2021 | 403 | 0.16 | Why? |
| Cell Line | 7 | 2021 | 12040 | 0.16 | Why? |
| Triazoles | 1 | 2021 | 440 | 0.16 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 449 | 0.16 | Why? |
| Endoribonucleases | 1 | 2021 | 407 | 0.16 | Why? |
| Drug Design | 4 | 2021 | 2627 | 0.15 | Why? |
| Disease Models, Animal | 4 | 2021 | 10998 | 0.15 | Why? |
| Methyltransferases | 1 | 2021 | 720 | 0.15 | Why? |
| Protein Multimerization | 1 | 2021 | 1336 | 0.14 | Why? |
| Adenine | 1 | 2017 | 463 | 0.14 | Why? |
| Acyclovir | 1 | 2015 | 154 | 0.14 | Why? |
| Pyrrolidines | 1 | 2017 | 558 | 0.13 | Why? |
| Genome-Wide Association Study | 1 | 2021 | 1648 | 0.13 | Why? |
| Fluorescent Dyes | 2 | 2020 | 536 | 0.13 | Why? |
| Blood-Brain Barrier | 1 | 2017 | 531 | 0.13 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Arthritis | 1 | 2017 | 288 | 0.13 | Why? |
| Chikungunya Fever | 1 | 2017 | 345 | 0.13 | Why? |
| Pyrimidines | 1 | 2021 | 1557 | 0.12 | Why? |
| Animals | 15 | 2021 | 78931 | 0.12 | Why? |
| Drug Evaluation, Preclinical | 2 | 2021 | 3347 | 0.12 | Why? |
| Inhibitory Concentration 50 | 3 | 2021 | 907 | 0.12 | Why? |
| Adenosine Monophosphate | 2 | 2021 | 5652 | 0.12 | Why? |
| Alanine | 2 | 2021 | 5687 | 0.12 | Why? |
| Microbial Sensitivity Tests | 5 | 2021 | 2886 | 0.12 | Why? |
| CRISPR-Cas Systems | 1 | 2021 | 1397 | 0.11 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.10 | Why? |
| Cell Death | 1 | 2012 | 536 | 0.10 | Why? |
| Antimalarials | 1 | 2021 | 2505 | 0.09 | Why? |
| Substrate Specificity | 2 | 2021 | 639 | 0.09 | Why? |
| Proteolysis | 1 | 2012 | 751 | 0.09 | Why? |
| Cyclophilins | 1 | 2008 | 76 | 0.08 | Why? |
| Pyrazines | 1 | 2017 | 1783 | 0.08 | Why? |
| Cell Survival | 1 | 2012 | 1581 | 0.08 | Why? |
| Small Molecule Libraries | 1 | 2014 | 1060 | 0.08 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.07 | Why? |
| Protease Inhibitors | 1 | 2020 | 3630 | 0.07 | Why? |
| Cyclosporine | 1 | 2008 | 449 | 0.07 | Why? |
| Signal Transduction | 1 | 2020 | 7207 | 0.07 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Drug Repositioning | 2 | 2021 | 5683 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Cell Line, Tumor | 2 | 2021 | 3608 | 0.06 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.06 | Why? |
| Combinatorial Chemistry Techniques | 1 | 2020 | 54 | 0.06 | Why? |
| Proviruses | 1 | 2021 | 82 | 0.05 | Why? |
| Glutamine | 1 | 2020 | 111 | 0.05 | Why? |
| Gene Expression | 2 | 2021 | 3332 | 0.05 | Why? |
| Peptides | 1 | 2012 | 2513 | 0.05 | Why? |
| Hydrophobic and Hydrophilic Interactions | 1 | 2021 | 382 | 0.05 | Why? |
| Protein Conformation, beta-Strand | 1 | 2020 | 414 | 0.05 | Why? |
| Virus Diseases | 1 | 2017 | 3779 | 0.05 | Why? |
| Coronavirus | 2 | 2021 | 18339 | 0.05 | Why? |
| RNA Caps | 1 | 2021 | 204 | 0.05 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2021 | 640 | 0.05 | Why? |
| Chemical Phenomena | 1 | 2018 | 22 | 0.05 | Why? |
| Protein Conformation, alpha-Helical | 1 | 2020 | 530 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.05 | Why? |
| Humans | 20 | 2021 | 930598 | 0.05 | Why? |
| Proof of Concept Study | 1 | 2021 | 696 | 0.05 | Why? |
| SARS Virus | 3 | 2020 | 13021 | 0.04 | Why? |
| Cathepsin L | 1 | 2021 | 566 | 0.04 | Why? |
| Caco-2 Cells | 1 | 2021 | 1236 | 0.04 | Why? |
| Host-Pathogen Interactions | 2 | 2021 | 11041 | 0.04 | Why? |
| Exoribonucleases | 1 | 2021 | 455 | 0.04 | Why? |
| HeLa Cells | 1 | 2020 | 1303 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2015 | 8843 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Glycoproteins | 1 | 2020 | 615 | 0.04 | Why? |
| Loperamide | 1 | 2014 | 13 | 0.04 | Why? |
| Mice | 3 | 2020 | 21357 | 0.03 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.03 | Why? |
| Catalytic Domain | 1 | 2020 | 1757 | 0.03 | Why? |
| Dogs | 1 | 2021 | 2529 | 0.03 | Why? |
| Chlorpromazine | 1 | 2014 | 130 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Crystallography, X-Ray | 1 | 2020 | 2689 | 0.03 | Why? |
| Chloroquine | 2 | 2021 | 3152 | 0.03 | Why? |
| Coronavirus OC43, Human | 1 | 2021 | 1157 | 0.03 | Why? |
| HIV-1 | 1 | 2008 | 3365 | 0.03 | Why? |
| Molecular Structure | 1 | 2018 | 1539 | 0.03 | Why? |
| Nucleosides | 1 | 2015 | 221 | 0.03 | Why? |
| Virus Internalization | 2 | 2021 | 7921 | 0.03 | Why? |
| Central Nervous System | 1 | 2017 | 701 | 0.03 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2021 | 3776 | 0.03 | Why? |
| Cysteine Endopeptidases | 1 | 2020 | 1557 | 0.03 | Why? |
| Hepatocytes | 1 | 2014 | 549 | 0.03 | Why? |
| Alleles | 1 | 2017 | 1557 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Cells, Cultured | 1 | 2021 | 5835 | 0.02 | Why? |
| Influenza A virus | 1 | 2021 | 2234 | 0.02 | Why? |
| Jurkat Cells | 1 | 2008 | 273 | 0.02 | Why? |
| Coronavirus Infections | 4 | 2021 | 253789 | 0.02 | Why? |
| HEK293 Cells | 1 | 2021 | 8394 | 0.02 | Why? |
| Interferon Type I | 1 | 2020 | 2789 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Computer Simulation | 1 | 2021 | 4982 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2017 | 3239 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Serine Endopeptidases | 1 | 2021 | 4606 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Drug Approval | 1 | 2014 | 1325 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.01 | Why? |
| Immunity, Innate | 1 | 2020 | 6570 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.01 | Why? |
| Antigens, Viral | 1 | 2017 | 6298 | 0.01 | Why? |
| Lopinavir | 1 | 2014 | 4308 | 0.01 | Why? |
| Female | 4 | 2021 | 380317 | 0.01 | Why? |
| Leukocytes, Mononuclear | 1 | 2008 | 2115 | 0.01 | Why? |
| Pneumonia, Viral | 3 | 2021 | 243684 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2021 | 12447 | 0.01 | Why? |
| Viral Load | 1 | 2017 | 15850 | 0.01 | Why? |
| Male | 3 | 2021 | 367725 | 0.01 | Why? |
| Lung | 1 | 2020 | 31049 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2017 | 48226 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2017 | 51949 | 0.00 | Why? |
| Pandemics | 2 | 2020 | 389249 | 0.00 | Why? |
| Middle Aged | 1 | 2021 | 270681 | 0.00 | Why? |
Jochmans's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(152)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(208)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_